Clinical Trials
34 trialsTotal Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer(CONTROL-01)
The Affiliated Hospital of Qingdao University
FOBEAR
Sun Yat-sen University
Morpheus
Sir Mortimer B. Davis - Jewish General Hospital
SOLAR
Kyungpook National University Hospital
NORAD01
Assistance Publique - Hôpitaux de Paris
Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer
Rutgers, The State University of New Jersey
GRECCAR15
University Hospital, Bordeaux
CHINOREC
Medical University of Vienna
A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer
Zhejiang Cancer Hospital
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
Alliance for Clinical Trials in Oncology
ESTIMATE
Yunnan Cancer Hospital
SILAR
Sun Yat-sen University
Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
Sun Yat-sen University
PelvEx II
Catharina Ziekenhuis Eindhoven
Long Term Bowel Function Following Rectal Cancer Surgery
Mansoura University
Neoadjuvant Therapy for Localized Rectal Adenocarcinoma
UNC Lineberger Comprehensive Cancer Center
Study to Nivolumab Following Preoperative Chemoradiotherapy
National Cancer Center Hospital East
Total Neoadjuvant Therapy in Rectal Cancer Treatment
State Scientific Centre of Coloproctology, Russian Federation
RectumSIB
Universitair Ziekenhuis Brussel
Rectal PET/MRI
University of California, San Francisco
Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Organ Preservation in Elderly Patients With Rectal Cancer
Maria Sklodowska-Curie National Research Institute of Oncology
Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
Sun Yat-sen University
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Royal Marsden NHS Foundation Trust
TNTCRT
West China Hospital
TRUST
Azienda Ospedaliero, Universitaria Pisana
SPRINT
Merck KGaA, Darmstadt, Germany
LARC-RRP
Oslo University Hospital
Phase I Study of CCRT as Adjuvant Treatment for Stage II/III Operable Rectal Cancer.
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Preoperative Radiotherapy and Local Excision in Rectal Cancer
Polish Colorectal Cancer Study Group
The Randomised Study of Preoperative Radiotherapy With Consolidating Chemotherapy for Unresectable Rectal Cancer
Polish Colorectal Cancer Study Group
Concurrent Chemo-Radiotherapy Versus Radiotherapy With Boost in Locally Advanced Unresectable Rectal Cancers
Tata Memorial Hospital